Co-Diagnostics (CODX) Tops Q2 EPS by $1.54, Beats on Revenue

Co-Diagnostics (NASDAQ: CODX) reported Q2 EPS of ($1.46), $1.54 better than the analyst estimate of ($3.00). Revenue for the quarter came in at $170 thousand versus the consensus estimate of $132.58 thousand.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• Saudi Arabia Oil Pipeline Struck By Projectiles Thursday - CNN
• Village Super Market (VLGEA) Declares $0.25 Quarterly Dividend; 2.3% Yield
• Active options: GOOGL AMD SMCI DELL MARA MSFT PLTR HOOD SNDK GME